← Evidence map

ReviewThe Lancet. Infectious diseases2026

Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development.

Francesca Saluzzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42223242